Loading clinical trials...
Loading clinical trials...
Ocena powikłań Naczyniowych u pacjentów Poddanych Rewaskularyzacji Obwodowej: wpływ inhibitorów SGLT-2 The Assessment of Vascular Complications in Patients Undergoing Peripheral Revascularization: The Impact of SGLT-2 Inhibitors
Conditions
Interventions
Treatment with SGLT2 inhibitors (flozins)
Locations
1
Poland
Wroclaw Medical University
Wroclaw, Lower Silesian Voivodeship, Poland
Start Date
July 1, 2025
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2026
Last Updated
March 23, 2026
NCT07097857
NCT06758921
NCT07499206
NCT06850207
NCT06618131
Lead Sponsor
Wroclaw Medical University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions